ANGLE plc (LON:AGL – Get Free Report) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 10.73 ($0.14) and traded as low as GBX 9.50 ($0.12). ANGLE shares last traded at GBX 9.60 ($0.12), with a volume of 1,123,393 shares.
Analysts Set New Price Targets
Separately, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 40 ($0.52) price target on shares of ANGLE in a report on Wednesday, January 29th.
View Our Latest Analysis on AGL
ANGLE Price Performance
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
See Also
- Five stocks we like better than ANGLE
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- How to Capture the Benefits of Dividend Increases
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- What Are Some of the Best Large-Cap Stocks to Buy?
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.